Related Articles

Tardive Dyskinesia and Other Neuroleptic-Induced Syndromes

Neuroleptics are medications that are named for its neurologic side effects of inducing parkinsonism (called drug-induced parkinsonism), a variety of other movement disorders, sensory disorders and an altered state of consciousness with fever.

Apr 19, 2023

Read more

Lurasidone-Induced Tardive Dyskinesia

Lurasidone is a novel atypical antipsychotic with additional antidepressant and pro-cognitive properties.

Apr–Jun 2022

Read more

Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder

Recognizing the negative impact that antipsychotic-induced movement disorders have on the quality of life and treatment outcomes in bipolar disorder (BD), this study aimed to assess clinical correlates and antipsychotic use patterns of tardive dyskinesia (TD+) in BD.

Mar 4, 2022

Read more

Tardive Dyskinesia and Dystonia – Clinical Case Review and Grand Rounds

Tardive dyskinesia (TD) syndromes are clinical conditions characterized by abnormal involuntary movements of the body and can range from occasional annoying involuntary movements to debilitating dystonia and are associated with increased mortality rates in schizophrenia.

Jan–Jun 2022

Read more

The Clinical and Economic Burden of Tardive Dyskinesia in Israel

Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by exposure to dopamine-receptor blockers. Data on TD burden in Israel are scarce. This analysis assesses the clinical and economic burden of TD in Israeli patients.

Sep 10, 2022

Read more

Vitamin E in the treatment of tardive dyskinesia: a meta-analysis

Long-term use of antipsychotic drugs is associated with tardive dyskinesia. At present, there is no satisfactory treatment for tardive dyskinesia. Some randomized trials suggested that vitamin E can improve tardive dyskinesia.

March 2022

Read more

Tardive Dyskinesia: Prevention and Newer Management Strategies

Tardive dyskinesia (TD) is a condition where we have a limited understanding of the cause and of management. The delayed-onset movements can occur due to prolonged exposure to dopamine receptor-blocking agents (DRBAs).

March 2022

Read more

Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia

To add to limited evidence on the Abnormal Involuntary Movement Scale (AIMS) as a measure of tardive dyskinesia (TD) in clinical practice settings, the characteristics and correlates of AIMS scores were assessed.

Jul 8, 2020

Read more

Teaching Video NeuroImages: Tardive diaphragmatic tremor

A 75-year-old woman was prescribed pimozide 2 mg twice a day 4 years previously for paranoid behavior. The patient developed involuntary movements in her abdomen following abrupt discontinuation of pimozide.

Jan 30, 2020

Read more

Dramatic improvement of tardive dyskinesia movements by inline skating

A 25-year-old woman with severe tardive dyskinesia (TD) due to neuroleptics had substantial improvement of movements while inline skating. She received pallidal deep brain stimulation (DBS), and gait and inline skating were assessed before and after DBS; her twin sister served as a control.

Jul 10, 2017

Read more